IRIS Accounts Production v23.3.0.418 07954239 director 1.3.22 28.2.23 28.2.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079542392022-02-28079542392023-02-28079542392022-03-012023-02-28079542392021-02-28079542392021-03-012022-02-28079542392022-02-2807954239ns10:Originalns15:EnglandWales2022-03-012023-02-2807954239ns14:PoundSterlingns10:Original2022-03-012023-02-2807954239ns10:Originalns10:Director12022-03-012023-02-2807954239ns10:Original2022-03-012023-02-2807954239ns10:Original2023-02-2807954239ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2807954239ns10:Originalns10:SmallEntities2022-03-012023-02-2807954239ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2807954239ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2807954239ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2807954239ns10:Originalns10:AbridgedAccounts2022-03-012023-02-2807954239ns10:CompanySecretary1ns10:Original2022-03-012023-02-2807954239ns10:Originalns10:RegisteredOffice2022-03-012023-02-2807954239ns10:Original2022-02-2807954239ns10:Originalns5:CurrentFinancialInstruments2023-02-2807954239ns10:Originalns5:CurrentFinancialInstruments2022-02-2807954239ns10:Originalns5:Non-currentFinancialInstruments2023-02-2807954239ns10:Originalns5:Non-currentFinancialInstruments2022-02-2807954239ns5:ShareCapitalns10:Original2023-02-2807954239ns5:ShareCapitalns10:Original2022-02-2807954239ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2807954239ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2807954239ns10:Originalns5:PlantMachinery2022-03-012023-02-2807954239ns10:Originalns5:FurnitureFittings2022-03-012023-02-2807954239ns10:Originalns5:ComputerEquipment2022-03-012023-02-2807954239ns10:Original2021-03-012022-02-2807954239ns10:Original2022-02-28
REGISTERED NUMBER: 07954239 (England and Wales)












Unaudited Financial Statements

for the Year Ended 28 February 2023

for

Link Medical Communications Limited

Link Medical Communications Limited (Registered number: 07954239)






Contents of the Financial Statements
for the Year Ended 28 February 2023




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


Link Medical Communications Limited

Company Information
for the Year Ended 28 February 2023







DIRECTOR: A Day





SECRETARY: M Day





REGISTERED OFFICE: 1 Stanyards Courtyard
Stanyards Farm
Chertsey Road
Chobham
Surrey
GU24 8JE





REGISTERED NUMBER: 07954239 (England and Wales)





ACCOUNTANTS: Ahmad York Limited
Chartered Certified Accountants
1 Stanyards Courtyard
Stanyards Farm
Chertsey Road
Chobham
Surrey
GU24 8JE

Link Medical Communications Limited (Registered number: 07954239)

Abridged Statement of Financial Position
28 February 2023

28.2.23 28.2.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 30,330 41,415
Investments 5 100 100
30,430 41,515

CURRENT ASSETS
Debtors 393,137 232,508
Cash at bank 22,055 65,479
415,192 297,987
CREDITORS
Amounts falling due within one year 54,224 52,055
NET CURRENT ASSETS 360,968 245,932
TOTAL ASSETS LESS CURRENT
LIABILITIES

391,398

287,447

CREDITORS
Amounts falling due after more than one
year

(70,703

)

(88,267

)

PROVISIONS FOR LIABILITIES (5,763 ) (7,869 )
NET ASSETS 314,932 191,311

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 314,832 191,211
SHAREHOLDERS' FUNDS 314,932 191,311

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Link Medical Communications Limited (Registered number: 07954239)

Abridged Statement of Financial Position - continued
28 February 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the year ended 28 February 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 November 2023 and were signed by:





A Day - Director


Link Medical Communications Limited (Registered number: 07954239)

Notes to the Financial Statements
for the Year Ended 28 February 2023

1. STATUTORY INFORMATION

Link Medical Communications Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Financial instruments
The company only enters into basic financial instrument transactions in accordance with Section 11. Financial assets and liabilities are measured at cost and financial assets are assessed at the end of each reporting period for objective evidence of impairment.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Link Medical Communications Limited (Registered number: 07954239)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 3 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2022 104,990
Additions 3,117
Disposals (13,764 )
At 28 February 2023 94,343
DEPRECIATION
At 1 March 2022 63,575
Charge for year 10,109
Eliminated on disposal (9,671 )
At 28 February 2023 64,013
NET BOOK VALUE
At 28 February 2023 30,330
At 28 February 2022 41,415

5. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 March 2022
and 28 February 2023 100
NET BOOK VALUE
At 28 February 2023 100
At 28 February 2022 100